Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study.
about
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosisPharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β.The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis.COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjectsPEGylated IFNβ-1a in the treatment of multiple sclerosis.Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological AgentsTNFR1 inhibition with a Nanobody protects against EAE development in mice.The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application.
P2860
Q28076879-0B5F2BF4-F787-460C-A594-0C71818A0F15Q30379738-17D32853-60C7-43F4-95DD-D80189A42E29Q33810082-C069B87C-B452-4B42-93EB-85F4C0C68655Q37149447-1DDF0184-725F-4DD8-8EA4-CB1A9272E8A2Q38513495-4CFE6AFB-7192-459B-8085-43DE1A5ADAE3Q38844529-BFCBF287-8707-4C24-BA77-83EFFC9AE1E4Q41198127-4560C646-5963-4FCC-82AC-8B7A1FB9DBB9Q42653357-48F121D7-C169-41A4-AFE8-F7DDFDC95BBEQ45854919-58C955DD-2200-4910-BE82-BA6C5978E6A3Q55429416-37EC8F16-A76A-4901-B2D1-0BD590BC8A7B
P2860
Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacokinetics and pharmacod ...... the randomized ADVANCE study.
@ast
Pharmacokinetics and pharmacod ...... the randomized ADVANCE study.
@en
type
label
Pharmacokinetics and pharmacod ...... the randomized ADVANCE study.
@ast
Pharmacokinetics and pharmacod ...... the randomized ADVANCE study.
@en
prefLabel
Pharmacokinetics and pharmacod ...... the randomized ADVANCE study.
@ast
Pharmacokinetics and pharmacod ...... the randomized ADVANCE study.
@en
P2093
P2860
P356
P1476
Pharmacokinetics and pharmacod ...... the randomized ADVANCE study.
@en
P2093
Aaron Deykin
Ivan Nestorov
Joleen White
Serena Hung
P2860
P304
P356
10.1111/BCP.12521
P407
P577
2015-03-01T00:00:00Z